tiprankstipranks
Trending News
More News >
Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX
US Market

Lineage Therap (LCTX) Cash flow

Compare
2,046 Followers

Lineage Therap Cash Flow

LCTX's free cash flow for Q3 2025 was $-3.63M. For the 2025 fiscal year, LCTX's free cash flow was decreased by $5.58M and operating cash flow was $-3.62M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -23.09M$ -28.57M$ 1.06M$ -23.56M$ -19.75M
Investing Cash Flow
$ -2.31M$ 46.45M$ -46.16M$ 9.74M$ 13.04M
Financing Cash Flow
$ 35.86M$ 6.42M$ 1.63M$ 36.93M$ 29.86M
End Cash Position
$ 46.35M$ 35.99M$ 11.94M$ 56.28M$ 33.18M
Free Cash Flow
$ -23.66M$ -29.24M$ 646.00K$ -23.91M$ -19.82M
Currency in USD

Lineage Therap Cash Flow